UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002216
Receipt number R000002639
Scientific Title AAA<aortic aneurismal remodeling by ARB> Study
Date of disclosure of the study information 2009/07/16
Last modified on 2014/06/25 14:28:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

AAA<aortic aneurismal remodeling by ARB> Study

Acronym

AAA<aortic aneurismal remodeling by ARB> Study

Scientific Title

AAA<aortic aneurismal remodeling by ARB> Study

Scientific Title:Acronym

AAA<aortic aneurismal remodeling by ARB> Study

Region

Japan


Condition

Condition

abdominal aortic aneurysm

Classification by specialty

Cardiology Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the pleiotropic effect(s) of ARB on remodeling of preoperative abdominal aortic aneurysm in comparison to that of CCB.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

changes in the maximum diameter of abdominal aortic aneurysm measured on the short axis

Key secondary outcomes

MACE, mortality, number of surgery, circulating biomarkers,
PWI/ABI, carotid arterial intimal thickness, cardiac diastolic function


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

AAA patients who is treated with ARB for 2 years

Interventions/Control_2

AAA patients who is treated with CCB for 2 years

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

AAA patients complicated with hypertension whose maximum short axis diameter of AAA is ranged from more than 3.0cm to less than 4.5cm.
aged more than 40years old
male
menopausal female
AAA patients with surgical indication who is preferred to medical control and/or who have been considered as inoperative.

Key exclusion criteria

female who is pregnant and supposed to be pregnant.
coronary spastic angina patients who is treated with calcium channel blocker.
malignancy
patients who refused the cooperation for this study.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toyoaki Murohara

Organization

Nagoya University Graduate School of Meidicine

Division name

Cardiology

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2196

Email

aaa-nagoya@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuko Bando

Organization

Nagoya University Graduate School of Meidicine

Division name

Cardiology

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2196

Homepage URL

http://www.AAA-nagoya.com

Email

aaa-nagoya@med.nagoya-u.ac.jp


Sponsor or person

Institute

Cardiology, Nagoya University Graduate School of Meidicine

Institute

Department

Personal name



Funding Source

Organization

Nagoya University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Saiseikai Kumamoto Hospital

Name of secondary funder(s)

Vascular Surgery, Nagoya University Graduate School of Meidicine


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学医学部附属病院(愛知県)、
名古屋大学循環器内科・血管外科関連病院(愛知県・岐阜県・三重県・静岡県)
済生会熊本病院(熊本県)


Other administrative information

Date of disclosure of the study information

2009 Year 07 Month 16 Day


Related information

URL releasing protocol

http://www.AAA-nagoya.com

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2009 Year 06 Month 18 Day

Date of IRB


Anticipated trial start date

2009 Year 06 Month 01 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry

2017 Year 09 Month 30 Day

Date trial data considered complete

2017 Year 09 Month 30 Day

Date analysis concluded

2017 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2009 Year 07 Month 16 Day

Last modified on

2014 Year 06 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002639


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name